MaaT Pharma fetches Series B

MaaT Pharma, a French clinical-stage oncology company, has secured 18 million euros in Series B financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this